North Carolina Wellness News: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on North Carolina Wellness News.

November 2025

Mo	Tu	We	Th	Fr	Sa	Su
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30

December 2025

Mo	Tu	We	Th	Fr	Sa	Su
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30	31

January 2026

Mo	Tu	We	Th	Fr	Sa	Su
			1	2	3	4
5	6	7	8	9	10	11
12	13	14	15	16	17	18
19	20	21	22	23	24	25
26	27	28	29	30	31

Press releases published on January 7, 2026

January 7, 2026

C3 HealthcareRx and Wellbox Health Merge to Form a Comprehensive Value-Based Care Organization

EIN Presswire

January 7, 2026

Chiropractic Expert Dr. Patrick Ess of Locust Clarifies Spinal Decompression for HelloNation

EIN Presswire

January 7, 2026

Scientists Discover Why Promising Alzheimer's Drugs Keep Failing, and Point to a Fix

EIN Presswire

January 7, 2026

Range Impact Announces Two Major Land Acquisitions in Kentucky and Sale of Abandoned Mine Land Services Business

GlobeNewswire

January 7, 2026

LENZ Therapeutics Reports Fourth Quarter 2025 Preliminary Unaudited Financial Results and Recent Corporate Updates

GlobeNewswire

January 7, 2026

MESA LABS DECLARES QUARTERLY DIVIDEND

GlobeNewswire

January 7, 2026

Built In Honors Xealth as a Top 10 Best Startup to Work for in Seattle

GlobeNewswire

January 7, 2026

Park Dental Partners Completes Acquisitions of Two Practices - Enters Phoenix Market and Expands Twin Cities Presence

GlobeNewswire

January 7, 2026

Onco360® Has Partnered with Rigel Pharmaceuticals to Add Three Therapies to Its Limited Distribution Portfolio

GlobeNewswire

January 7, 2026

Jasper Therapeutics Appoints Jeet Mahal as Chief Executive Officer to Lead Next Phase of Clinical Growth

GlobeNewswire

January 7, 2026

Globus Medical Reports Preliminary Record Fourth Quarter and Full Year Sales Results

GlobeNewswire

January 7, 2026

Sana Biotechnology to Present at the 44th Annual J.P. Morgan Healthcare Conference

GlobeNewswire

January 7, 2026

Abivax Provides 2026 Corporate Outlook

GlobeNewswire

January 7, 2026

Krystal Biotech to Announce Interim Clinical Update from Highest Dose Cohort of Phase 1 CORAL-1 Study Evaluating KB407 in Patients with Cystic Fibrosis

GlobeNewswire

January 7, 2026

Sutro Biopharma to Present at the 44th Annual J.P. Morgan Healthcare Conference

GlobeNewswire

January 7, 2026

Ultragenyx to Present at the 44th Annual J.P. Morgan Healthcare Conference

GlobeNewswire

January 7, 2026

RAPT Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference

GlobeNewswire

January 7, 2026

iMDx Announces “JPM Week” and “BTIG Snowbird” Conference Participation

GlobeNewswire

January 7, 2026

Terns Pharmaceuticals to Highlight 2026 Priorities and Program Milestones at the 44th Annual J.P. Morgan Healthcare Conference

GlobeNewswire

January 7, 2026

BioStem Technologies Comments on Withdrawal of CMS CY 2026 Final Medicare Reimbursement Rule for Skin Substitutes

GlobeNewswire